Skip to main content

Zusammenfassung

Für die Pädiatrie klinisch wichtige Störungen des Lipidstoffwechsels umfassen Veränderungen der Plasmalipoproteine mit und ohne Hyperlipidämien, Lipidspeicherkrankheiten sowie Störungen der Fettsäureoxidation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Colletti RB, Neufeld EJ, Roff NK, McAuliffe TL, Baker AL, Newburger JW (1993) Niacin treatment of hypercholesterolemia in children. Pediatrics 92 (1): 78–82

    CAS  PubMed  Google Scholar 

  • Eng CM, Guffon N, Wilcox WR et al. (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry’s disease. N Engl.’ Med 345 (1): 9–16

    Article  CAS  Google Scholar 

  • ESPGAN Committee on Nutrition (1994) Comment on childhood diet and prevention of coronary heart disease. J Pediatr Gastroenterol Nutr 19: 261–269

    Google Scholar 

  • LIPID Study Group (Long term Intervention with Pravastatin in-Ischaemic Disease) (2002) Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet 359 (9315): 1379–1387

    Article  Google Scholar 

  • Koletzko B, Ullrich K, Becker M, Beisiegel U, Schwandt P (1995) Diagnostik and Therapie der Hypercholesterinämie bei Kindern and Jugendlichen. Empfehlungen der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen. Monatsschr Kinderheilkd 143: 1041–1042

    Google Scholar 

  • Koletzko B, Dokoupil K, Schenk U von (1996) Hast Du auch hohes Cholesterin? Ein Ernährungsberater für Kinder and Eltern. Steinkopff, Darmstadt

    Google Scholar 

  • McGuinness MC, Wei H, Smith KD (2000) Therapeutic developments in peroxisome biogenesis disorders. Expert Opin Investig Drugs 9 (9): 1985–1992

    Article  CAS  PubMed  Google Scholar 

  • Roe CR (2002) Inherited disorders of mitochondria) fatty acid oxidation: a new responsibility for the neonatologist. Semin Neonatol 7 (1): 37–47

    Article  PubMed  Google Scholar 

  • Schiffmann R, Kopp JB, Austin HA et al. (2001) Enzyme replacement therapy in fabry disease: a randomized controlled trial. JAMA 285 (21): 2743–2749

    Article  CAS  PubMed  Google Scholar 

  • Scriver CR, Beaudet AL, Valle D, Sly WS (eds) (2001) The metabolic and molecular basis of inherited disease. McGraw Hill, New York

    Google Scholar 

  • Wanders RJ, Vreken P, Boer ME den, Wijburg FA, Gennip AH van, Ijlst L (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis 22 (4): 442–487

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Koletzko, B. (2004). Störungen des Lipid- und Lipoproteinstoffwechsels. In: Reinhardt, D. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10471-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10471-2_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10472-9

  • Online ISBN: 978-3-662-10471-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics